Dr. Javier E. Lopez, MD

Dr. Lopez practices at Neuroscience Consultants in South Miami, Florida.

Dr. Lopez's NPI, 1508800442, was assigned on June 15, 2006. Dr. Lopez graduated from University of Puerto Rico, Medical Sciences Campus in 1998. Dr. Lopez holds Florida license ME84768.

Dr. Lopez's primary practice is Neuroscience Consultants, at 7000 Sw 62nd Ave, South Miami, FL 33143 in Miami-Dade County. The practice phone is (786) 924-1311.

Dr. Lopez's primary practice is Neuroscience Consultants in South Miami, Florida. Dr. Lopez is also affiliated with Baptist Health Baptist Hospital. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Lopez to 3 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lopez practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lopez's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lopez is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lopez's licenses on file in 2 states: Florida and Maine.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Lopez treats.

CMS data shows 1,178 Medicare services from Dr. Lopez across 10 procedure codes in 2024, for 408 Medicare patients. Medicare paid $120,846 for them.

CMS counts 408 Medicare patients who saw Dr. Lopez in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lopez's median patient age at 71, with 67% women.

In 2024, Dr. Lopez wrote 4,898 Medicare Part D claims for 578 patients. 89% of them were for generic drugs. CMS names the drug for 4,425 of them, across 93 drugs with 11 or more claims each, at $1,343,984 in total drug cost. In 2023, CMS named 3,880 claims across 84 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lopez for performance year 2024, reported individually. Dr. Lopez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lopez as offering telehealth. CMS counts 12 procedures of skin biopsy by Dr. Lopez, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 35 papers to Dr. Lopez, published from 2007 to 2014. 2012 was the busiest year, with 4. The most frequent topics are Aging, Antifungal Agents and Antiviral Agents. Dr. Lopez has published most often in Phys Rev E Stat Nonlin Soft Matter Phys. Dr. Lopez's most frequent co-authors are Bruce D. Adams, MD, Jose Ignacio Lopez, MD and Paul R. Tarnasky, MD.

CMS Open Payments shows 2,258 general payments to Dr. Lopez from 96 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. UCB, Inc. paid the most, $4,897.

Dmand AI lists 1 award for Dr. Lopez.

Dr. Lopez graduated from University of Puerto Rico, Medical Sciences Campus in 1998. Dr. Lopez is a member of AAN and Florida Society of Neurology.

Dr. Lopez is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.